Entrada Therapeutics Inc - TRDA - Share chat

This company aims to transform the treatment of devastating diseases and improve patients’ quality of life by developing intracellular biologics. It uses its proprietary Endosomal Escape Vehicle (EEV)™ platform to create a diverse and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to efficiently target and engage underlying drivers of diseases.